Abstract
Detection of specific IgE using component resolved diagnostics (CRD) identifies the underlying allergen source in suspected cases of tree and grass pollen allergy. Suitable marker allergens can be used to distinguish genuine sensitization to tree or grass pollen from cross-reactivity to pollen panallergens (e. g. profilin and polcalcins) and to overcome the lack of analytical specificity of natural allergen extracts. In patients reacting with a variety of pollen extracts suspected of polysensitization, CRD allows allergen specific diagnosis regardless of the confounding effect of panallergenic cross-reactivity and administration of tailored, specific immunotherapy.
In this article, allergens indicating specific sensitization to grass and tree pollen are described. Allergens defined as marker allergens for tree and grass pollen allergy are Bet v 1 (birch pollen major allergen) for birch, beech and other trees from the Fagales order, Ole e 1 (olive pollen major allergen) for olive and other trees including ash from the Oleaceae family, Pla a 1 (major allergen of the London plane tree) for plane trees, Cry j 1 (major allergen of the Japanese cedar), Cup a 1 (major allergen of the Arizona cypress) for cypress trees and Phl p 1 und 5 (Timothy grass major allergens) for sweet grasses including rye. Grass and tree pollen allergens with serological and clinical cross-reactivity to a great number of allergen sources are also identified as possible confounding factors in allergen specific diagnosis with natural extracts. Structured diagnostic procedures for clinical routine work are proposed.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Marker allergens
Many allergens from botanically related sources share structural similarities resulting in IgE-cross-reactivity. As a consequence, allergens sharing similar structures are often also related on an immunological level and patients sensitized to one specific allergen may show clinical or in vitro reactivity to other structurally similar allergenic proteins. Different IgE sensitization profiles can be identified in allergic patients according to reactivity to certain allergens. These allergens are defined as marker allergens [1, 2, 3].
Today, genuine allergic sensitization can be differentiated from cross-reactivity using modern component resolved allergy diagnostic (CRD) [4]. In grass and tree pollen allergy, CRD can identify the appropriate immunotherapy in poly-sensitized patients. Since specific immunotherapy is time-consuming (taking up to several years) and burdensome, early identification of patients suffering from genuine sensitization to grass or tree pollen who should benefit from a specific immunotherapy is important.
Allergens, which pinpoint genuine sensitization and may be defined as marker allergens for specific tree and grass pollen allergies, shall be described in this article.
Allergen sources in trees and grasses
Tree and grass pollen from wind pollinated plants are a frequent source of allergens. Between 12 and 17 % of the general population in Europe suffer from grass pollen allergy with almost 10 % suffering from tree pollen allergy [5, 6]. After hydration, tree and grass pollen rapidly release large amounts of allergens, i. e. defined IgE-binding proteins and glycoproteins. Upon contact with the mucosal surfaces of the respiratory tract, these allergens trigger allergic symptoms in susceptible patients [7, 8].
Grasses
Most allergenic grasses belong to the botanical family of sweet grasses (Poaceae) mainly found in temperate climate zones. As examples, Timothy grass (Phleum pratense), rye grass (Lolium perenne), orchard grass (Dactylis glomerata), Kentucky blue grass (Poa pratensis) belong to the Pooideae subfamily and are closely related. Other grasses, such as Bermuda grass (Cynodon dactylon), rice (Oryza sativa), common reed (Phragmites communis) and Bahia grass (Paspalum notatum) belong to the Chloridoideae, Ehrhartoideae, Arundinoideae und Panicoideae subfamilies, respectively, found in hot and tropical climate zones [9, 10, 11, 12]. An overview of the botanical relationship between grasses is shown in Fig. 1.
Trees
Unlike grass pollen, allergenic tree pollen originates from different botanical groups of spermatophytes occurring in different geographical regions [13, 14, 15]. The following overview and Fig. 2 have been compiled according to the principles of phylogenetic classification [16, 17].
The majority of trees are flowering plants (angiosperms). An important group of cross-reactive allergenic tree pollen originates from two families of the order Fagales:
-
The Betulaceae family (birch, Betula verrucosa; alder, Alnus glutinosa; hazelnut, Corylus avellana and hornbeam, Carpinus betulus) and
-
the Fagaceae family (oak, Quercus alba; common beech, Fagus sylvatica and chestnut, Castanea sativa).
Trees of the family Oleaceae (order Lamiales) are the source of a second important group of cross-reactive allergenic pollen and are an important source of allergens in the Mediterranean region [18]. The olive tree (Olea europaea) is the most widely spread species. Other allergenic members of the Oleaceae family are privets (Ligustrum vulgare), lilac (Syringa vulgaris) and ash trees (Fraxinus excelsior).
In some areas of the Mediterranean, different species of plane tree (order Proteales, family Platanaceae) represent a locally important source of allergens originating from angiosperms.
Another important source of cross-reactive allergenic pollen originates from the botanical group of gymnosperms. The most important trees belong to the order of Cupressales, (family Cupressaceae) such as the Arizona cypress (Cupressus arizonica) and the Japanese cedar (Cryptomeria japonica) [13, 15, 19].
Important grass pollen allergens
Tab. 1 gives an overview of the most important grass pollen allergens.
Allergens found in all Poaceae grasses
Marker allergen for all sweet grasses — Group 1 (Phl p 1): Group-1 allergens have been isolated and/or cloned from more than twenty Poaceae species [9, 20, 21, 22, 23]. Phl p 1 is the group-1 allergen of Timothy grass. It has a sequence identity of between 85 and 95 % with other members of the Pooideae subfamily. Most amino acid substitutions found in isoforms and in group-1 allergens of other Pooideae species (e. g. Hol l 1, Poa p 1 und Lol p 1) do not significantly alter allergenicity of the molecule [9, 11, 22, 24]. Most IgE-epitopes of Phl p 1 cluster at the c-terminus [25]. Up to 90 % of all grass pollen allergic patients show IgE-reactivity to group-1 allergens of other grass species [9, 11, 22, 26, 27]. Phl p 1 is the most important group-1 allergen and represents an important cross-reactive major allergen. Cross-reactivity of group-1 allergens has been demonstrated in many studies with natural extracts of different Pooideae species and other Poaceae subfamilies [11, 24, 27]. Purified recombinant Phl p 1 inhibited binding of patient sera to natural extracts of eight different grasses (Timothy grass, Phleum pratense; sweet vernal grass, Anthoxatum odoratum; oat, Avena sativa; Bermuda grass, Cynodon dactylon; rye grass, Lolium perenne; common reed, Phragmites communis; Kentucky blue grass, Poa pratensis; rye, Secale cereale) inducing an average inhibition of 76 % [26]. Monoclonal antibodies raised against Phl p 1 and defining four distinct epitopes as well as recombinant human Phl p 1-specific IgE-Fabs (fragment antigen binding) recognize and bind to a panel of natural group-1 allergens of different Pooideae grasses [25, 28].
Sequence homologies and cross-reactivity between Phl p 1 and group-1 allergens of tropical and subtropical grasses such as Bermuda grass (Cynodon dactylon; 67–70 % sequence identity) or Bahia grass (Paspalum notatum) are less pronounced [9, 11, 29]. There is no complete cross-inhibition between group-1 allergens of grasses originating in temperate climate zones and group-1 allergens of grasses originating in tropical climate zones, especially with patient sera from tropical climate zones (overview presented in [28]). However, there are indications that these species-specific Ig-E epitopes are not protein epitopes, but carbohydrate epitopes without clinical relevance [30].
Phl p 1 is the most important marker allergen for genuine sensitization to grasses belonging to all subfamilies of Poaceae for the following reasons:
Approximately 90 % of grass pollen allergic patient sera contain specific IgE against Phl p 1,
group-1 allergens have been found in all Poaceae grasses, but not in other taxonomically unrelated plants,
there is wide-spread cross-reactivity between group-1 allergens from different grass species.
Group-13: The group-13 grass pollen allergen, a 55 kDa-protein, has also been described in all grasses examined to date [31]. Although over 50 % of grass pollen allergic patients display IgE-reactivity against Phl p 13, it has only little clinical relevance as it showed only low allergenic reactivity in clinical and in vitro studies [32].
Allergens found only in Pooideae grasses
Marker allergen for Pooideae — Group-5 (Phl p 5): Group-5 allergens are marker allergens for Pooideae grasses. Homologous allergens have been found in all grasses of the Pooideae subfamily, such as Timothy grass (Phleum pratense), rye (Secale cereale), Kentucky blue gras (Poa pratense) and rye grass (Lolium perenne). Group-5 allergens are not found in grasses belonging to the Panicoideae, Chloridoideae, Ehrhartoideae or Arundinoideae subfamilies, which are mainly distributed in the Southern hemisphere and are highly prevalent in tropical and subtropical climate zones. Group-5 allergens are not found in corn (Zea mays), Bermuda grass (Cynodon dactylon) or rice (Oryza sativa), for example [33].
Phl p 5, one of the best characterized group-5 allergens, is one of several allergens to occur in different isoallergenic forms as Phl p 5a (i. e. Phl p 5.01) and Phl p 5b (i. e. Phl p 5.02). The overall sequence identity between Phl p 5a and Phl p 5b is approximately 65 % but is higher (70–77 %) in important parts of the molecule. Between 65 and 85 % of grass pollen allergic patients in temperate climate zones display IgE-reactivity to group-5 allergens and the clinical allergenic activity of Phl p 5a is very high [9, 32, 34, 35].
Most patients display extensive IgE cross-reactivity to the Phl-p-5 isoallergens as well as to different group-5 allergens from Pooideae grasses. [9, 33, 36].
Phl p 5 is therefore an important marker allergen for sensitization to grasses of the Pooideae subfamily.
Other Pooideae-specific allergens: Group-2/3 and group-6 allergens are also only found in the pollen of Pooideae grasses. In some populations more than 50 % of grass pollen allergic patients display IgE-reactivity to these molecules, yet, the overall rate of patient sensitization is not high enough to give them the status of marker allergens (for an overview see [9, 37]). Athough patient IgE titers against group-2/3 allergens are often rather low, Phl p 2 shows high allergenic activity in skin tests [32]. The allergenic activity of Phl p 6 has not been tested yet in clinical studies.
Group-11 allergens are not very important in the clinic. Although few patients react with these allergens, they have been found in Phleum pratense and Lolium perenne [38] and homologues from other plants e. g. olive (Ole e 1), corn (Zea m 13) and tomato, have been identified. Cross-reactivity between homologues from taxonomically unrelated allergen sources is very limited.
Marker allergens for grass pollen allergy: Summary
Group-1 and group-5 allergens account for 60–80 % of grass pollen allergic patient IgE in different populations from different geographic areas [26]. Extensive cross-inhibition of patient IgE binding to nine different grass pollen extracts (sweet vernal grass, Anthoxanthum odoratum; oat, barley, Avena sativa; Bermuda grass, Cynodon dactylon; rye grass, Lolium perenne; common reed, Phragmites australis; Kentucky blue grass, Poa pratensis; rye, Secale cereale; wheat, Triticum sativum; corn, Zea mays) was achieved with a small panel of purified, recombinant, grass pollen allergens (Phl p 1, Phl p 2 and Phl p 5) and profilin (Bet v 2) [33]. In a clinical vaccination study involving 64 subjects, patients were sucessfully treated with a mixture of recombinant Phl p1, Phl p2, Phl p 5a+b and Phl p 6 [39]. A proof of principle has thus been established that successful therapy of grass pollen allergy is possible using a combination of distinct grass pollen specific and clinically important allergens.
Group-1 and group-5 allergens, such as Phl p 1 and Phl p 5, are therefore the most suitable marker allergens for diagnosis of grass pollen allergy in temperate climate zones.
Carbohydrate sensitivity in grass pollen allergic patients
Phl p 1, Phl p 4, Phl p 11 and Phl p 13 are glycoproteins carrying cross-reactive carbohydrate determinants (CCD). Using CCD-free, recombinant allergens in allergen CRD has the advantage that only functional IgE (i. e. capable of IgE-aggregation) directed against protein epitopes is detected. For instance, up to 85 % of grass pollen allergic patients have detectable group-4 allergen-specific IgE. Group-4 allergens are glycoproteins with a molecular weight of 50–67 kDa. However, specific IgE in patient sera is often rather low and despite in-vitro reactivity, no clinical reactivity has been described [9, 32, 40, 41]. In tropical regions, IgE cross-reactivity is based nearly exclusively on CCD of these glycoproteins [30] and in temperate climate zones, the frequency of sensitization seen in patient sera is less than 60 % if recombinant Phl p 4 is used for diagnosis [42].
Phl p 4 homologous proteins are found in ambrosia and birch pollen, as well as in peanut, apple, celery and carrot, but clinical significance remains unclear [43].
Important tree pollen allergens
Tab. 2 gives an overview of the most important tree pollen allergens.
Allergens of trees of the order Fagales
Marker allergen for Fagales — Bet v 1: The cDNA (complementary deoxyribonucleic acid) of Bet v 1, the major allergen of birch, was isolated in 1989 [44], the 17-kDa-protein allergen was produced using recombinant gene technology and IgE-reactivity in up to 95 % of birch pollen allergic patients was detected [45, 46].
The major allergens of other tree pollen in the order of Fagales from the families of
-
Betulaceae (ash, Alnus glutinosa, Aln g 1; hornbeam, Carpinus betulus, Car p 1; hazelnut, Corylus avellana, Cor a 1) and
-
Fagaceae (oak, Quercus alba, Que a 1; chestnut, Castanea sativa, Cas s 1; common beech, Fagus sylvatica, Fag s 1)
all show pronounced cross-reactivities and sequence homologies within the group and to Bet v 1 [13, 14, 45, 47]. Together, they form a group known as pathogenesis related proteins (PR-10). Recombinant Bet v 1 inhibits IgE-reactivity of patient sera with other tree pollen of the Fagales order [48]. A great number of proteins from different plant foods (nuts, vegetables and spices) display homology and cross-reactivity to Bet v 1 e. g.: apple (Malus domestica, Mal d 1), hazelnut (Corylus avellana, Cor a 1), sweet cherry (Prunus avium, Pru av 1), apricot (Prunus armeniaca, Pru ar 1), peach (Prunus persica, Pru p 1), pear (Pyrus communis, Pyr c 1), carrot (Daucus carota, Dau c 1), celery (Apium graveolens, Api g 1) and soy bean (Glycine max, Gly m 4) [14, 15, 49, 50] and are responsible for birch-pollen related oral allergy syndrome [51].
Due to the high number of IgE-binding epitopes, Bet v 1 is thought to be the original sensitizing protein in clinically manifest allergy to Fagales pollen or in oral allergy syndrome [1, 15, 52]. In birch pollen allergic patients, exposure to birch pollen primarily increases Bet v 1-specific IgE without increasing IgE to other birch pollen allergens such as Bet v 2 [53]. Allergy patients in central Africa reacting with natural birch pollen extracts, do not display IgE-antibodies against Bet v 1 but against other birch pollen allergens [54].
Several studies have shown that subcutaneous immunotherapy with birch pollen extract alone is equally effective as therapy with a mixture of different Fagales tree pollen extracts in tree pollen allergic patients [55, 56]. Allergy diagnosis (skin test, specific IgE) with recombinant Bet v 1 is as effective in detecting birch pollen allergic patients as diagnosis using natural birch pollen extracts [57].
As a consequence of these in vitro and in vivo data, Bet v 1 represents the marker allergen for sensitization to Fagales tree pollen and the associated oral allergy syndrome.
Other Fagales-specific minor allergens: Bet v 6 (formerly known as Bet v 5), an isoflavone reductase, is a minor allergen which is cross-reactive with pollen and proteins from several edible plants (fruits, vegetables and spices); Bet v 7 is a cyclophilin. Both are recognized by less than 20 % of birch pollen allergic patients. Bet v 8 is a pectin esterase with a clinical significance that has yet to be determined. (For an overview see [13, 14] and Tab. 2).
Allergens of trees of the order Lamiales
Marker allergen for Lamiales — Ole e 1: Ole e 1, the most important olive pollen allergen, exists in a non-glycosylated (19 kDa) and a glycosylated (21 kDa) form and is recognized by more than 70 % of olive pollen allergic patients [58]. It displays substantial sequence homologies with other members of the Ole-e-1- like protein family. This protein family derives from pollen of other Oleaceae species (for an overview see [59]) such as
-
ash tree(Fraxinus excelsior, Fra e 1),
-
privet (Ligustrum vulgare, Lig v 1) and
-
lilac (Syringa vulgaris, Syr v 1).
Moreover this protein family comprises
-
Pla l 1 from plantain (Plantago lanceolata, family of Plantaginaceae)
as well as allergens from taxonomically unrelated species such as
-
Lol p 11 from Lolium perenne (rye grass),
-
Phl p 11 from Phleum pratense, (timothy grass) and
-
Che a 1 from Chenopodium album (mercury goosefoot).
There is extensive cross-reactivity between Ole-e-1 homologous allergens of the Oleaceae (Overview in [3]). IgE from sera of two different groups of European patients, one group of which was sensitized to olive pollen the other to ash pollen, was inhibited from binding to extracts of different Oleaceae pollen by Ole e 1. Birch pollen, grass pollen and weed pollen extracts did not inhibit patient IgE binding to Ole e 1 [60] showing the existence of specific epitopes for Oleaceae pollen in Ole e 1.
In patients from regions without distribution of olive pollen such as Austria, Germany or Northern Italy, specific IgE against Ole e 1 indicates a sensitization to ash pollen (Fraxinus excelsior, Fra e 1) [61, 62]. This is relevant in patients showing clinical symptoms during the birch pollen season, but who are not sensitized to birch or any other member of the Fagales order [60].
Ole e 1 is the marker allergen for sensitization to olive pollen and is important in this respect in the Mediterranean region. In regions whithout olive pollen, Ole e 1 can be used as a marker allergen for sensitization to ash pollen.
The group-11 grass pollen allergens Phl p 11 and Lol p 11 are members of the Ole-e-1-like protein family due to structural homologies and sequence homologies (e. g. approximately 30 % sequence identity between Ole e 1 and Phl p 11). However, they do not share any IgE-epitopes with Ole e 1 and no significant cross-reactivity was detected between Ole e 1 and Phl p 11 or Lol p 11 [60].
Other Lamiales-specific allergens: Other specific minor allergens of olive pollen have been described (for an overview see [59] and Tab. 2). Ole e 7 is a member of the non-specific lipid-transfer-protein (LTP) family. Sensitization to Ole e 7 is associated with a tendency for severe allergic reactions, however, cross-reactivity with other unspecific LTP-proteins seems to be limited [63]. In some regions of Southern Spain, an elevated prevalence of sensitization against Ole e 7 and Ole e 9 was seen and in some regions, up to 40 % of Ole-e-1-negative allergic patients are sensitized to Ole e 7 [64]. Ole e 9 und Ole e 10 are also possibly associated with cross-reactivity to birch, tomatoe, potatoe, bell pepper, banana and latex [65, 66].
Allergens of trees of the order Proteales
Tree pollen from trees of the Platanaceae family, genus Platanus, comprising about ten species (e. g. London plane tree, Platanus acerifolia), are highly cross-reactive and induce severe symptoms in a small number of sensitized patients. In regions with many plane trees such as Spain, peaks of allergy symptoms are seen during the wind pollination season [67]. Pla a 1 from the London plane tree, an invertase inhibitor, is recognized by up to 90 % of all plane tree allergic patients and is therefore considered a major allergen of plane trees [68]. Pla a 1 is used as a marker allergen for plane tree allergy (Tab. 2), however, the allergen Pla a 2, a polygalacturonase, may also be important in this respect [68, 69].
Allerges of trees of the order Cupressales
Pollen from trees of the Cupressaceae family (e. g. Arizona cypress, Cupressus arizonica; Japanese cedar, Cryptomeria japonica) are highly cross-reactive (for an overview see [13, 19]). The prevalence of allergy to different Cupressaceae pollen has increased in central Europe, even though Cupressaceae trees are distributed mainly in the Mediterranean region [70]. It is possible that allergy to Cupressales pollen was underestimated for a long time, because the flowering season is in winter (January to March/April) and clinical symptoms of allergy to Cupressales may have been mistaken for the common cold, or thought to be caused by perennial allergens such as from house dust mite [71].
Cry j 1 (from Japanese cedar) is a 40-kDa-protein and was the first Cupressaceae allergen to be described [72]. Together with Cup a 1 from the Arizona cypress [73], it is considered the marker allergen of Cupressales pollen allergy. Both allergens are glycosylated pectate lyases. Although the major allergen of ragweed (Ambrosia artemisiifolia, Amb a 1), is also a pectate lyase, there is only very limited cross-reactivity with Cry j 1 and Cup a 1.
Panallergens: Markers for cross-reactivity
Panallergens are found in grass and tree pollen as well as in many other botanically unrelated plants. They belong either to the polcalcin (calcium binding allergens carrying two, three or four binding sites for calcium, so-called EF-hands) or profilin protein families. Amino acid sequences of both protein families are highly conserved regardless of the taxonomical relationship of allergenic plant species leading to extensive immunological cross-reactivity. Therefore, they are considered marker allergens for cross-reactivity in the diagnosis of grass and tree pollen allergy [74].
Polcalcins
Members of the polcalcin protein family (approximately 9 kDa proteins) from tree and grass pollen include the
-
2-EF-hand-proteins Bet v 4, Aln g 4, Ole e 3, Cyn d 7 and Phl p 7, the
-
3-EF-hand-protein Bet v 3 and the
-
4-EF-hand-protein Ole e 8.
Polcalcins have only been found in the pollen of trees, grasses and weeds. For instance, approximately 10 % of grass pollen allergic patients have specific IgE to Phl p 7, but in sensitized patients, Phl p 7 displays a high allergenic activity [1, 74, 75].
Profilins
Profilin (Bet v 2, 15 kDa) was first identified in birch pollen [77] and has since been found in the pollen of many grasses (e. g. Phl p 12, Cyn d 12), trees (e. g. Ole e 2) and weeds, but also in plant derived food and latex (for an overview see [1, 78]). The amount of specific patient IgE varies according to geographical region and allergen source and is found in approximately 10–30 % of pollen allergic patients.
Panallergens: Summary
Cross-inhibition experiments with polcalcins and profilins from different sources have confirmed extensive cross-reactivity of these allergens; the highest IgE-reactivity is observed with the grass pollen allergens Phl p 7 and Phl p 12 [76, 78].
Phl p 7 and Phl p 12 are therefore considered marker allergens for cross-reactivity and the presence of specific IgE to either in patient sera may explain clinical symptoms upon exposure to a range of different allergen sources.
In grass pollen allergy, sensitization to Phl p 7 and 12 is often seen in a late post-clinical phase after sensitization to Phl p 1 and Phl p 5 [79] and may be considered as marker allergens for clinically manifest grass pollen allergy.
Structured approach to clinical routine work (Fig. 3)
Diagnostic tests with marker allergens
Phl p 1/Phl p 5 (marker for grass pollen),
Bet v 1 (marker for beech and birch trees, other Fagales trees and the related oral allergy syndrome),
Ole e 1 (marker for olive trees and other Oleaceae trees including ash),
Pla a 1 (marker for plane trees),
Cup a 1/Cry j 1 (marker for cypress trees)
and with the panallergens (e. g. Timothy grass-polcalcin/profilin)
Phl p 7/Phl p 12 (indicators for cross-reactivity)
establish a patient allergen-specific sensitization profile to tree and grass pollen allergens.
Conclusions for clinical routine work
Genuine sensitization to grass pollen in Europe is reliably diagnosed with a combination of the major grass pollen allergens Phl p 1 und Phl p 5. If sensitization to Phl p 1 without IgE-reactivity to Phl p 5 (and in addition, no reactivity to Phl p 2/3 and Phl p 6) is found, this may be due to sensitization to one of the tropical/subtropical grass sub-families.
Specific IgE to Bet v 1 characterizes sensitization to Fagales trees (birch, alder, hornbeam, hazelnut, common beech, oak, chestnut) and related oropharyngeal symptoms (oral allergy syndrome) due to reactions with cross-reactive plant-derived foods (e. g. apple, hazelnut, pear, sweet cherry, peach, carrot, celery, soy bean) [51].
Ole e 1 is the major allergen in olive pollen. It displays extensive sequence identity and cross-reactivity with other major allergens of the Oleaceae family such as ash, privet and lilac. In the Mediterranean region, genuine sensitization to olive pollen is diagnosed with Ole e 1; in more temperate climate zones such as central Europe, Ole e 1 can be used to prove sensitization to ash pollen and to distinguish it from the clinical symptoms of birch pollen allergy occurring in the same season.
Sensitization to tree pollen of the Platanaceae family is diagnosed with Pla a 1 (possibly including Pla a 2), sensitization to pollen of trees of the Cupressaceae family with Cup a 1/Cry j 1.
Association of the above mentioned marker allergens with specific clinically relevant sensitization profiles was confirmed in clinical studies [80, 81, 82].
If no clear-cut sensitization to one of the above-mentioned marker allergens can be detected, the following rules apply:
-
Low or no IgE-reactivity to genuine marker allergens indicates that a patient is not sensitized to the corresponding allergen source. An allergen extract from this source is not suitable for specific immunotherapy.
-
Exclusive sensitization to the panallergens profilin and polcalcin (e. g. Phl p 7 and Phl p 12 from Timothy grass pollen) is very rare. This sensitization profile often cannot be attributed to one specific allergen source. Patients therefore are not suited for specific immunotherapy.
-
The presence of specific IgE to profilin and/or polcalcin by nature of their cross-reactivity rules out further diagnosis with natural (pollen) extracts, as sensitization to panallergens abolishes analytical specificity (selectivity) of natural extracts.
In these cases, allergy CRD together with a detailed patient history should be used to reach a therapeutic decision. This will ensure that the correct decision for or against specific immunotherapy and its correct composition is taken [83, 84].
Abbreviations
- CCD:
-
Cross-reactive carbohydrate determinants
- cDNA:
-
Complementary deoxyribonucleic acid
- CRD:
-
Component resolved diagnostic
- Fab:
-
Fragment antigen binding
- IgE:
-
Immunoglobulin E
- LTP:
-
Lipid transfer protein
- nsLTP:
-
Non-specific lipid transfer protein
- OAS:
-
Oral allergy syndrome
- PR-10:
-
Pathogenesis related proteins
References
Kazemi-Shirazi L, Niederberger V, Linhart B, Lidholm J, Kraft D, Valenta R. Recombinant marker allergens: diagnostic gate keepers for therapy of allergy. Int Arch Allergy Immunol 2002;127:259–68
Suphioglu C. What are the important allergens in grass pollen that are linked to human allergic diseases? Clin Exp Allergy 2000;30:1335–41
Valenta R, Twaroch T, Swoboda I. Component-resolved diagnosis to optimize allergen-specific immunotherapy in the Mediterranean area. J Investig Allergol Clin Immunol 2007;17 (Suppl 1):88–92
Hiller R, Laffer S, Harwanegg C, Huber M, Schmidt WM, Twardosz A et al. Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment. FASEB J 2002;16:414–6
Blomme K, Tomassen P, Lapeere H, Huvenne W, Bonny M, Acke F et al. Prevalence of allergic sensitization versus allergic rhinitis symptoms in an unselected population. Int Arch Allergy Immunol 2013;160:200–7
Wüthrich B, Schindler C, Leuenberger P, Ackermann-Liebrich U. Prevalence of atopy and pollinosis in the adult population of Switzerland (SAPALDIA study). Swiss Study on Air Pollution and Lung Diseases in Adults. Int Arch Allergy Immunol 1995;106:149–56
Grote M, Vrtala S, Niederberger V, Wiermann R, Valenta R, Reichelt R. Release of allergen-bearing cytoplasm from hydrated pollen: a mechanism common to a variety of grass (Poaceae) species revealed by electron microscopy. J Allergy Clin Immunol 2001;108:109–15
Vrtala S, Grote M, Duchêne M, Ree R van, Kraft D, Scheiner O, Valenta R. Properties of tree and grass pollen allergens: reinvestigation of the linkage between solubility and allergenicity. Int Arch Allergy Immunol 1993;102:160–9
Andersson K, Lidholm J. Characteristics and immunobiology of grass pollen allergens. Int Arch Allergy Immunol 2003;130:87–107
Hejl C, Wurtzen PA, Kleine-Tebbe J, Johansen N, Broge L, Ipsen H. Phleum pratense alone is sufficient for allergen specific immunotherapy against allergy to Pooideae grass pollens. Clin Exp Allergy 2009;39:752–9
Johansen N, Weber RW, Ipsen H, Barber D, Broge L, Hejl C. Extensive IgE cross-reactivity towards the Pooideae grasses substantiated for a large number of grass-pollen-sensitized subjects. Int Arch Allergy Immunol 2009;150:325–34
Simon BK, Clayton WD, Harman KT, Vorontsova M, Brake I, Healy D, Alfonso Y. GrassWorld 2011. http://grassworld.myspecies.info/en/node/20919. Zugegriffen 22.09.2014
Marth K, Garmatiuk T, Swoboda I, Valenta R. Tree pollen allergens. In: Lockey RF, Ledford DK, eds. Allergens and allergen immunotherapy, 5th ed. London: CRC Press; 2014
Mothes N, Horak F, Valenta R. Transition from a botanical to a molecular classification in tree pollen allergy: implications for diagnosis and therapy. Int Arch Allergy Immunol 2004;135:357–73
Swoboda I, Twaroch T, Valenta R, Grote M. Tree pollen allergens. Clin Allergy Immunol 2008;21:87–105
APG III. An update of the Angiosperm Phylogeny Group classification for the orders and families of flowering plants: APG III. Botanical Journal of the Linnean Society 2009;161:105–21
Christenhusz MJM, Reveal JL, Farjon A, Gardner MF, Mill RR, Chase MW. A new classification and linear sequence of extant gymnosperms. Phytotaxa 2011;19:55–70
Bousquet J, Cour P, Guerin B, Michel FB. Allergy in the Mediterranean area. I. Pollen counts and pollinosis of Montpellier. Clin Allergy 1984;14:249–58
Di Felice G, Barletta B, Tinghino R, Pini C. Cupressaceae pollinosis: identification, purification and cloning of relevant allergens. Int Arch Allergy Immunol 2001;125:280–9
Griffith IJ, Smith PM, Pollock J, Theerakulpisut P, Avjioglu A, Davies S et al. Cloning and sequencing of Lol p I, the major allergenic protein of rye-grass pollen. FEBS Lett 1991;279:210–5
Johnson P, Marsh DG. ‘Isoallergens’ from rye grass pollen. Nature 1965;206:935–7
Laffer S, Valenta R, Vrtala S, Susani M, Ree R van, Kraft D et al. Complementary DNA cloning of the major allergen Phl p I from timothy grass (Phleum pratense); recombinant Phl p I inhibits IgE binding to group I allergens from eight different grass species. J Allergy Clin Immunol 1994;94:689–98
Perez M, Ishioka GY, Walker LE, Chesnut RW. cDNA cloning and immunological characterization of the rye grass allergen Lol p I. J Biol Chem 1990;265:16210–5
Laffer S, Vrtala S, Duchêne M, Ree R van, Kraft D, Scheiner O, Valenta R. IgE-binding capacity of recombinant timothy grass (Phleum pratense) pollen allergens. J Allergy Clin Immunol 1994;94:88–94
Flicker S, Steinberger P, Ball T, Krauth MT, Verdino P, Valent P et al. Spatial clustering of the IgE epitopes on the major timothy grass pollen allergen Phl p 1: importance for allergenic activity. J Allergy Clin Immunol 2006;117:1336–43
Laffer S, Duchene M, Reimitzer I, Susani M, Mannhalter C, Kraft D, Valenta R. Common IgE-epitopes of recombinant Phl p I, the major timothy grass pollen allergen and natural group I grass pollen isoallergens. Mol Immunol 1996;33:417–26
Ree R van, Driessen MN, Leeuwen WA van, Stapel SO, Aalberse RC. Variability of crossreactivity of IgE antibodies to group I and V allergens in eight grass pollen species. Clin Exp Allergy 1992;22:611–7
Duffort O, Quintana J, Ipsen H, Barber D, Polo F. Antigenic similarity among group 1 allergens from grasses and quantitation ELISA using monoclonal antibodies to Phl p 1. Int Arch Allergy Immunol 2008;145:283–90
Davies JM. Grass pollen allergens globally: the contribution of subtropical grasses to burden of allergic respiratory diseases. Clin Exp Allergy 2014;44:790–801
Cabauatan CR, Lupinek C, Scheiblhofer S, Weiss R, Focke-Tejkl M, Bhalla PL et al. Allergen microarray detects high prevalence of asymptomatic IgE sensitizations to tropical pollen-derived carbohydrates. J Allergy Clin Immunol 2014;133:910–13
Suck R, Hagen S, Cromwell O, Fiebig H. The high molecular mass allergen fraction of timothy grass pollen (Phleum pratense) between 50-60 kDa is comprised of two major allergens: Phl p 4 and Phl p 13. Clin Exp Allergy 2000;30:1395–402
Westritschnig K, Horak F, Swoboda I, Balic N, Spitzauer S, Kundi M et al. Different allergenic activity of grass pollen allergens revealed by skin testing. Eur J Clin Invest 2008;38:260–7
Niederberger V, Laffer S, Fröschl R, Kraft D, Rumpold H, Kapiotis S et al. IgE antibodies to recombinant pollen allergens (Phl p 1, Phl p 2, Phl p 5 and Bet v 2) account for a high percentage of grass pollen-specific IgE. J Allergy Clin Immunol 1998;101:258–64
Flicker S, Vrtala S, Steinberger P, Vangelista L, Bufe A, Petersen A et al. A human monoclonal IgE antibody defines a highly allergenic fragment of the major timothy grass pollen allergen, Phl p 5: molecular, immunological, and structural characterization of the epitope-containing domain. J Immunol 2000;165:3849–59
Vrtala S, Sperr WR, Reimitzer I, Ree R van, Laffer S, Müller WD et al. cDNA cloning of a major allergen from timothy grass (Phleum pratense) pollen; characterization of the recombinant Phl pV allergen. J Immunol 1993;151:4773–81
Ree R van. Isoallergens: a clinically relevant phenomenon or just a product of cloning? Clin Exp Allergy 2002;32:975–8
Gangl K, Niederberger V, Valenta R. Multiple grass mixes as opposed to single grasses for allergen immunotherapy in allergic rhinitis. Clin Exp Allergy 2013;43:1202–16
Marknell DeWitt A, Niederberger V, Lehtonen P, Spitzauer S, Sperr WR, Valent P et al. Molecular and immunological characterization of a novel timothy grass (Phleum pratense) pollen allergen, Phl p 11. Clin Exp Allergy 2002;32:1329–40
Jutel M, Jaeger L, Suck R, Meyer H, Fiebig H, Cromwell O. Allergen-specific immunotherapy with recombinant grass pollen allergens. J Allergy Clin Immunol 2005;116:608–13
Niederberger V, Stubner P, Spitzauer S, Kraft D, Valenta R, Ehrenberger K, Horak F. Skin test results but not serology reflect immediate type respiratory sensitivity: a study performed with recombinant allergen molecules. J Invest Dermatol 2001;117:848–51
Zafred D, Nandy A, Pump L, Kahlert H, Keller W. Crystal structure and immunologic characterization of the major grass pollen allergen Phl p 4. J Allergy Clin Immunol 2013;132:696–703
Tripodi S, Frediani T, Lucarelli S, Macrì F, Pingitore G, Di Rienzo Businco A et al. Molecular profiles of IgE to Phleum pratense in children with grass pollen allergy: implications for specific immunotherapy. J Allergy Clin Immunol 2012;129:834–9
Grote M, Stumvoll S, Reichelt R, Lidholm J, Valenta R. Identification of an allergen related to Phl p 4, a major timothy grass pollen allergen, in pollens, vegetables, and fruits by immunogold electron microscopy. Biol Chem 2002;383:1441–5
Breiteneder H, Pettenburger K, Bito A, Valenta R, Kraft D, Rumpold H et al. The gene coding for the major birch pollen allergen, Bet v 1, is highly homologous to a pea disease resistance response gene. EMBO J 1989;8:1935–8
Valenta R, Duchene M, Vrtala S, Birkner T, Ebner C, Hirschwehr R et al. Recombinant allergens for immunoblot diagnosis of tree pollen allergy. J Allergy Clin Immunol 1991;88:889–94
Menz G, Dolecek C, Schonheit-Kenn U, Ferreira F, Moser M, Schneider T et al. Serological and skin test diagnosis of birch pollen allergy with recombinant Bet v 1, the major birch pollen allergen. Clin Exp Allergy 1996;26:50–60
Ipsen H, Hansen OC. The NH2-terminal amino acid sequence of the immunochemically partial identical major allergens of alder (Alnus glutinosa) Aln g I, birch (Betula verrucosa) Bet v I, hornbeam (Carpinus betulus) Car b I and oak (Quercus alba) Que a I pollens. Mol Immunol 1991;28:1279–88
Niederberger V, Pauli G, Gronlund H, Froschl R, Rumpold H, Kraft D et al. Recombinant birch pollen allergens (rBet v 1 and rBet v 2) contain most of the IgE epitopes present in birch, alder, hornbeam, hazel and oak pollen: a quantitative IgE inhibition study with sera from different populations. J Allergy Clin Immunol 1998;102:579–91
Heiss S, Fischer S, Muller WD, Weber B, Hirschwehr R, Spitzauer S et al. Identification of a 60 kDa cross-reactive allergen in pollen and plant-derived food. J Allergy Clin Immunol 1996;98:938–47
Kazemi-Shirazi L, Pauli G, Purohit A, Spitzauer S, Fröschl R, Hoffmann-Sommergruber K et al. Quantitative IgE inhibition experiments with purified recombinant allergens indicate pollen-derived allergens as the sensitizing agents responsible for many forms of plant food allergy. J Allergy Clin Immunol 2000;105:116–25
Kleine-Tebbe J, Balmer-Weber B, Breiteneder H, Vieths S. Bet v 1 und Homologe - Verursacher der Baumpollenallergie und birkenpollenassoziierter Kreuzreaktionen. Serie Molekulare Allergologie - Teil 2. Allergo J 2010;19:462–4.
Moverare R, Westritschnig K, Svensson M, Hayek B, Bende M, Pauli G et al. Different IgE reactivity profiles in birch pollen-sensitive patients from six European populations revealed by recombinant allergens: an imprint of local sensitization. Int Arch Allergy Immunol 2002;128:325–35
Birkner T, Rumpold H, Jarolim E, Ebner H, Breitenbach M, Skvaril F et al. Evaluation of immunotherapy-induced changes in specific IgE, IgG and IgG subclasses in birch pollen allergic patients by means of immunoblotting. Correlation with clinical response. Allergy 1990;45:418–26
Westritschnig K, Sibanda E, Thomas W, Auer H, Aspöck H, Pittner G et al. Analysis of the sensitization profile towards allergens in central Africa. Clin Exp Allergy 2003;33:22–7
Henzgen M, Wenz W, Strümpfel R. Experiences with desensitization of early spring pollen allergy using 2 tree pollen extracts. Z Gesamte Inn Med 1989;44:691–3
Petersen BN, Janniche H, Munch EP, Wihl JA, Böwadt H, Ipsen H, Løwenstein H. Immunotherapy with partially purified and standardized tree pollen extracts. I. Clinical results from a three-year double-blind study of patients treated with pollen extracts either of birch or combinations of alder, birch and hazel. Allergy 1988;43:353–62
Tresch S, Holzmann D, Baumann S, Blaser K, Wüthrich B, Crameri R, Schmid-Grendelmeier P. In vitro and in vivo allergenicity of recombinant Bet v 1 compared to the reactivity of natural birch pollen extract. Clin Exp Allergy 2003;33:1153–8
Villalba M, Batanero E, Löpez-Otín C, Sänchez LM, Monsalve RI, Gonzälez de la Peña MA et al. The amino acid sequence of Ole e I, the major allergen from olive tree (Olea europaea) pollen. Eur J Biochem 1993;216:863–9
Rodríguez R, Villalba M, Batanero E, Palomares O, Quiralte J, Salamanca G et al. Olive pollen recombinant allergens: value in diagnosis and immunotherapy. J Investig Allergol Clin Immunol 2007:17 (Suppl 1):56–62
Palomares O, Swoboda I, Villalba M, Balic N, Spitzauer S, Rodriguez R, Valenta R. The major allergen of olive pollen Ole e 1 is a diagnostic marker for sensitization to Oleaceae. Int Arch Allergy Immunol 2006;141:110–8
Asero R. Analysis of hypersensitivity to oleaceae pollen in an olive-free and ash-free area by commercial pollen extracts and recombinant allergens. Eur Ann Allergy Clin Immunol 2011;43:77–80
Niederberger V, Purohit A, Oster JP, Spitzauer S, Valenta R, Pauli G. The allergen profile of ash (Fraxinus excelsior) pollen: cross-reactivity with allergens from various plant species. Clin Exp Allergy 2002;32:933–41
Tordesillas L, Sirvent S, Díaz-Perales A, Villalba M, Cuesta-Herranz J, Rodríguez R, Salcedo G. Plant lipid transfer protein allergens: no cross-reactivity between those from foods and olive and Parietaria pollen. Int Arch Allergy Immunol 2011;156:291–6
Barber D, Moreno C, Ledesma A, Serrano P, Galán A, Villalba M et al. Degree of olive pollen exposure and sensitization patterns. Clinical implications. J Investig Allergol Clin Immunol 2007;17 (Suppl 1):11–6
Palomares O, Villalba M, Quiralte J, Polo F, Rodríguez R. 1,3-β-glucanases as candidates in latex-pollen-vegetables food cross-reactivity. Clin Exp Allergy 2005;35:345–51
Quiralte J, Palacios L, Rodríguez R, Cárdaba B, Arias de Saavedra JM, Villalba M et al. Modelling diseases: the allergens of Olea europaea pollen. J Investig Allergol Clin Immunol 2007;17 (Suppl 1):24–30
Varela S, Subiza J, Subiza JL, Rodríguez R, García B, Jerez M et al. Platanus pollen as an important cause of pollinosis. J Allergy Clin Immunol 1997;100:748–54
Asturias JA, Ibarrola I, Bartolomé B, Ojeda I, Malet A, Martínez A. Purification and characterization of Pla a 1, a major allergen from Platanus acerifolia pollen. Allergy 2002;57:221–7
Asturias JA, Ibarrola I, Amat P, Tella R, Malet A, Cisteró-Bahíma A et al. Purified allergens vs. complete extract in the diagnosis of plane tree pollen allergy. Clin Exp Allergy 2006;36:1505–12
Panzner P, Vachová M, Vítovcová P, Brodská P, Vlas T. A comprehensive analysis of middle-European molecular sensitization profiles to pollen allergens. Int Arch Allergy Immunol 2014;164:74–82
D’Amato G, Cecchi L, Bonini S, Nunes C, Annesi-Maesano I, Behrendt H et al. Allergenic pollen and pollen allergy in Europe. Allergy 2007;62:976–90
Yasueda H, Yui Y, Shimizu T, Shida T. Isolation and partial characterization of the major allergen from Japanese cedar (Cryptomeria japonica) pollen. J Allergy Clin Immunol 1983;71:77–86
Aceituno E, Del Pozo V, Mínguez A, Arrieta I, Cortegano I, Cärdaba B et al. Molecular cloning of major allergen from Cupressus arizonica pollen: Cup a 1. Clin Exp Allergy 2000;30:1750–8
Hauser M, Wallner M, Ferreira F, Mahler V, Kleine-Tebbe J. Das Konzept der Pollen-Panallergene: Profiline und Polcalcine. Serie Molekulare Allergologie - Teil 9. Allergo J 2012; 21:291–3.
Niederberger V, Hayek B, Vrtala S, Laffer S, Twardosz A, Vangelista L et al. Calcium-dependent immunoglobulin E recognition of the apo- and calcium-bound form of a cross-reactive two EF-hand timothy grass pollen allergen, Phl p 7. FASEB J 1999;13:843–56
Tinghino R, Twardosz A, Barletta B, Puggioni EM, Iacovacci P, Butteroni C et al. Molecular, structural, and immunologic relationships between different families of recombinant calcium-binding pollen allergens. J Allergy Clin Immunol 2002;109:314–20
Valenta R, Duchene M, Pettenburger K, Sillaber S, Valent P. Identification of profilin as a novel pollen allergen; IgE autoreactivity in sensitized individuals. Science 1991;253:557–60
Radauer C, Willerroider M, Fuchs H, Hoffmann-Sommergruber K, Thalhamer J, Ferreira F et al. Cross- reactive and species-specific immunoglobulin E epitopes of plant profilins: an experimental and structure-based analysis. Clin Exp Allergy 2006;36:920–9
Hatzler L, Panetta V, Lau S, Wagner P, Bergmann RL, Illi S et al. Molecular spreading and predictive value of preclinical IgE response to Phleum pratense in children with hay fever. J Allergy Clin Immunol 2012;130:894–901
Canis M, Gröger M, Becker S, Klemens C, Kramer MF. Recombinant marker allergens in diagnosis of patients with allergic rhinoconjunctivitis to tree and grass pollens. Am J Rhinol Allergy 2011;25:36–9
Jahn-Schmid B, Harwanegg C, Hiller R, Bohle B, Ebner C, Scheiner O, Mueller MW. Allergen microarray: comparison of microarray using recombinant allergens with conventional diagnostic methods to detect allergen-specific serum immunoglobulin E. Clin Exp Allergy 2003;33:1443–9
Twardosz-Kropfmüller A, Singh MB, Niederberger V, Horak F, Kraft D, Spitzauer S et al. Association of allergic patients’ phenotypes with IgE reactivity to recombinant pollen marker allergens. Allergy 2010;65:296–303
Douladiris N, Savvatianos S, Roumpedaki I, Skevaki C, Mitsias D, Papadopoulos NG. A molecular diagnostic algorithm to guide pollen immunotherapy in southern Europe: towards component-resolved management of allergic diseases. Int Arch Allergy Immunol 2013;162:163–72
Letrán A, Espinazo M, Moreno F. Measurement of IgE to pollen allergen components is helpful in selecting patients for immunotherapy. Ann Allergy Asthma Immunol 2013;111:295–7
Author information
Authors and Affiliations
Corresponding author
Additional information
Acknowledgements
This article was supported by projects SFB 4613 and SFB 4605 of the FWF (Austrian science fund).
Conflict of interest
The authors declare that there are no conflicts of interest.
Cite this as
Gangl K, Niederberger V, Valenta R, Nandy A. Marker allergens and panallergens in tree and grass pollen allergy — Part 17 of the Series Molecular Allergology. Allergo J Int 2015;24:158–69
Rights and permissions
About this article
Cite this article
Gangl, K., Niederberger, V., Valenta, R. et al. Marker allergens and panallergens in tree and grass pollen allergy. Allergo J Int 24, 158–169 (2015). https://doi.org/10.1007/s40629-015-0055-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40629-015-0055-3